Infliximab: A Breakthrough Biologic Transforming Autoimmune Care
Did you know that modern biologic medicines can target the source of inflammation instead of simply managing symptoms? 🩺
Infliximab is a widely used biologic therapy that has transformed the treatment of several chronic autoimmune diseases by helping reduce inflammation, improve quality of life, and support long-term disease management under medical supervision.
Infliximab was developed through advances in biotechnology during the 1990s as researchers sought more targeted treatments for autoimmune conditions. It became one of the first biologic therapies designed to block tumor necrosis factor-alpha (TNF-α), a protein that plays a major role in causing inflammation. Since its introduction, infliximab has been used in hospitals and specialty clinics worldwide to help manage conditions such as rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis. Its success has also encouraged the development of additional biologic medicines and biosimilars, expanding treatment options for patients and healthcare providers.
There…

